Glycated haemoglobin A1c

1 paper

Human trial1

Latest

1 in 12 months

Diabetes, Obesity & Metabolism8 Oct

Kidney Outcomes With GLP-1 Receptor Agonists and Tirzepatide Versus Finerenone in Type 2 Diabetes and Chronic Kidney Disease: A Real-World Cohort Study

Cohort study of 4,554 peopleGLP-1 receptor agonists

The Lancet Healthy Longevity1 Jul

Effects of putative metformin targets on phenotypic age and leukocyte telomere length: a mendelian randomisation study using data from the UK Biobank

Mendelian randomisation in peopleTelomerase and telomere maintenance

Lancet4 Oct

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Randomised trial in 316 peopleGLP-1 receptor agonists

PLOS One28 Mar

Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity

Cohort study of 1,293 peopleMetabolic syndrome

Lancet12 Jul

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

Randomised trial in 1,450 peopleCanagliflozin